Klaria Pharma Holding AB (publ) - ESG Rating & Company Profile powered by AI
The assessment of Klaria Pharma Holding AB (publ) incorporates intelligence from across the internet and also from public filings by Klaria Pharma Holding AB (publ). Alternative companies in the scoring industry group for Klaria Pharma Holding AB (publ) are shownin the table. The ESG rating includes 17 UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'.
Klaria Pharma Holding AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 0.0, social score of 5.3 and governance score of 5.3.
3.5
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1144 | Veerhealth Care Ltd | 3.6 | Medium |
1144 | iStreet Network Ltd | 3.6 | Medium |
1186 | Klaria Pharma Holding AB (publ) | 3.5 | Medium |
1186 | CRISPR Therapeutics AG | 3.5 | Medium |
1186 | Catalent Inc | 3.5 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Klaria Pharma Holding AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Does Klaria Pharma Holding AB (publ) disclose current and historical energy intensity?
Does Klaria Pharma Holding AB (publ) report the average age of the workforce?
Does Klaria Pharma Holding AB (publ) reference operational or capital allocation in relation to climate change?
Does Klaria Pharma Holding AB (publ) disclose its ethnicity pay gap?
Does Klaria Pharma Holding AB (publ) disclose cybersecurity risks?
Does Klaria Pharma Holding AB (publ) offer flexible work?
Does Klaria Pharma Holding AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Klaria Pharma Holding AB (publ) disclose the number of employees in R&D functions?
Does Klaria Pharma Holding AB (publ) conduct supply chain audits?
Does Klaria Pharma Holding AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Klaria Pharma Holding AB (publ) conduct 360 degree staff reviews?
Does Klaria Pharma Holding AB (publ) disclose the individual responsible for D&I?
Does Klaria Pharma Holding AB (publ) disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Klaria Pharma Holding AB (publ) disclose current and / or historical scope 2 emissions?
Does Klaria Pharma Holding AB (publ) disclose water use targets?
Does Klaria Pharma Holding AB (publ) have careers partnerships with academic institutions?
Did Klaria Pharma Holding AB (publ) have a product recall in the last two years?
Does Klaria Pharma Holding AB (publ) disclose incidents of discrimination?
Does Klaria Pharma Holding AB (publ) allow for Work Councils/Collective Agreements to be formed?
Has Klaria Pharma Holding AB (publ) issued a profit warning in the past 24 months?
Does Klaria Pharma Holding AB (publ) disclose parental leave metrics?
Does Klaria Pharma Holding AB (publ) disclose climate scenario or pathway analysis?
Does Klaria Pharma Holding AB (publ) disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Klaria Pharma Holding AB (publ) disclose the pay ratio of women to men?
Does Klaria Pharma Holding AB (publ) support suppliers with sustainability related research and development?
Does Klaria Pharma Holding AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Klaria Pharma Holding AB (publ) reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Klaria Pharma Holding AB (publ) involved in embryonic stem cell research?
Does Klaria Pharma Holding AB (publ) disclose GHG and Air Emissions intensity?
Does Klaria Pharma Holding AB (publ) disclose its waste policy?
Does Klaria Pharma Holding AB (publ) report according to TCFD requirements?
Does Klaria Pharma Holding AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Klaria Pharma Holding AB (publ) disclose energy use targets?
Does Klaria Pharma Holding AB (publ) disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Klaria Pharma Holding AB (publ) have a policy relating to cyber security?
Have a different question?
Potential Risks for Klaria Pharma Holding AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.